Clinical Trials Browser

Phase 4 × Terminated × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all

NCT02228382 2021-12-30

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Phase 4 Terminated

163 enrolled 27 charts

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02204722 2018-06-15

IDEAL

Phase 4 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02086487 2017-03-07

NISRI

Phase 4 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00461929 2009-02-13

GIST

Phase 4 Terminated

MyeloidOther hematologic neoplasm

Chromosome Aberrations, Leukemia, Myelogenous, Chronic, BCR-ABL Positive